Liver-directed therapies for gastrointestinal malignancies

Current Opinion in Oncology

Volumn 9, Issue 4, 1997, Pages 367-372

  McMurrick, Paul J ^a   Nelson, Heidi ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; DOXORUBICIN; FLUOROURACIL; FOLINIC ACID; IODINATED POPPYSEED OIL; LEVAMISOLE; YTTRIUM 90;

ARTIFICIAL EMBOLISM; CANCER SCREENING; CANCER STAGING; CANCER SURGERY; COLORECTAL CANCER; CRYOSURGERY; HEALTH CARE COST; HEPATIC ARTERY; HUMAN; ISOTOPE LABELING; LIVER CELL CARCINOMA; LIVER METASTASIS; LIVER TRANSPLANTATION; LIVER TUMOR; MICROWAVE IRRADIATION; PORTAL VEIN; PRIORITY JOURNAL; REVIEW;

EID: 0030741560     PISSN: 10408746     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001622-199709040-00010     Document Type: Review

References (34)

1. Liver (including intrahepatic bile ducts). In American Joint Committee on cancer: manual for staging of cancer, edn 4. Philadelphia: JB Lippincott: 1992:89-91.
2. Shimada M, Takenaka K, Kawahara N, Kajiyama K, Yamamoto K, Shirabe K, Nickizake T, Yanaga K, Sugimachi K: Surgical treatment strategy for patients with stage IV hepatocellular carcinoma. Surgery 1996. 119(5):517-522.
3. Izumi R, Shimizu K, Ii T, Yagi M, Matsui O, Nonomura A, Miyazaki I: Prognostic factors of hepatocellular carcinoma in patients undergoing hepatic resection. Gastroenterology 1994, 106:720-727.
4. Di Bisceglie A, Rusti V, Hoofnagle J, et al.: NIH conference: hepatocellular carcinoma. Ann Intern Med 1988, 108(3):390-401.
5. Mazzaferro V, Regalia E, Doci R, Andreola S, Pulvirenti A, Bozzetti F. •• Montalto F, Ammatuna M, Morabito A, Gennari L: Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 1996, 334(11):693-699. Key article describing favorable outcome in 48 patients undergoing liver transplantation in the setting of small HCC, with a 4-year survival rate of 75%.
6. Ojogho O, Keeffe E, Berquist W, Concepcion W, Garcia-Kennedy R, Imperial J, Esquivel C: Orthotopic liver transplantation for hepatocellular carcinoma: factors affecting long-term patient survival. Arch Surg 1996, 131(9):935-939.
7. Ferris J, Baron R, March J, Oliver J III, Carr B, Dodd G III: Recurrent hepatocellular carcinoma after liver transplantation: spectrum of CT findings and recurrence patterns. Radiology 1996, 198(1):233-238.
8. Ko S, Nakajima Y, Kanehiro H, Aomatsu Y, Yoshimura A, Taki J, Kin T, Yagura K, Oyama T, Yagi M, Shimomura H, Nakano H: Liver transplantation for hepatocellular carcinoma: consideration from the findings on autopsy. Transplant Proc 1996, 28(3):1691-1692.
9. Bronowicki J, Boudjema K, Chone L, Nisand G, Bazin C, Pflumio F, Uhl G, Wenger J, Jaeck D, Boissel P, Bigard M, Gaucher P, Vetter D, Doffoel M: Comparison of resection, liver transplantation and transcatheter oily chemoembolisation in the treatment of hepatocellular carcinoma. J Hepatol 1996, 24(3):293-300.
10. Sato M, Watanabe Y, Ueda S, Abe Y, Sato N, Kimura S, Okubo K, Onji M: Microwave coagulation therapy for hepatocellular carcinoma. Gastroenterology 1996, 110(5):1507-14.
11. Tian J, Xu B, Zhang J, Dong B, Liang P, Wang X: Ultrasound-guided internal radiotherapy using yttrium-90-glass microspheres for liver malignancies. J Nucl Med 1996, 37(6):958-963.
12. Ryder S, Rizzi P, Metivier E, Karani J, Williams R: Chemoembolisation with lipiodol and doxorubicin: applicability in British patients with hepatocellular carcinoma. Gut 1996, 38(1):125-128.
13. Tanikawa K: Non-invasive loco-regional therapy for hepatocellular carcinoma. Semin Surg Oncol 1996, 12(3):189-192.
14. Arii S, Okamoto E, Imamura M: Registries in Japan: current status of •• hepatocellular carcinoma in Japan. Liver Cancer Study Group of Japan. Semin Surg Oncol 1996, 12(3):204-211. A summary of results of treatment of more than 11,000 patients with HCC in Japan. Demonstrates near equivalent outcome for patients treated with surgical resection versus percutaneous ethanol injection.
15. Shiina S, Imamura M, Obi S, Teratani T, Kanai F, Kato N, Niwa Y, Okudaira T, Payawal D, Tateishi R, Shiratori Y, Omata M: Percutaneous ethanol injection therapy for small hepatocellular carcinoma. Japn J Cancer Chemother 1996, 23(7):835-839.
16. Ishii H, Okada S, Nose H, Okusaka T, Yoshimon M, Takayama T, Kosuge T, Yamasaki S, Sakamoto M, Hirohsahi S: Local recurrence of hepatocellular carcinoma after percutaneous ethanol injection. Cancer 1996, 77(9):1792-1796.
17. Yokoi H, Kawarada Y: Current status of treatment for small hepatocellular carcinoma. Japn Cancer Chemother 1996, 23(7):855-861.
18. Steele G Jr, Bleday R, Mayer R, Lindblad A, Petrelli N, Weaver D: A prospective evaluation of hepatic resection for colorectal carcinoma metastases to the liver: Gastrointestinal Tumor Study Group Protocol 6584. J Clin Oncol 1991, 9:1105-1112.
19. Beart R, Moertel C, Wieand H, Leigh J, Windshitl H, van Heerden J, Fitzgibbons R, Wolff B: Adjuvant therapy for resectable colorectal carcinoma with fluorouracil administered by portal vein infusion: a study of the Mayo Clinic and the North Central Cancer Treatment Group. Arch Surg 1990, 125(7):897-901.
20. Swiss Group for Clinical Cancer Research (SAKK): Long term results of a single course of adjuvant intraportal chemotherapy for colorectal cancer. Lancet 1995, 345:349-353.
21. Piedbois P, Buyse M, Gray R, et al.: Portal vein infusion is an effective • adjuvant treatment for patients with colorectal cancer [abstract]. Proc Am Soc Clin Oncol 1995, 14:192. Abstract presentation of a meta-analysis of more than 3,400 patients undergoing portal vein infusion after curative resection of colorectal carcinoma, demonstrating a reduction in recurrence and prolongation of survival.
22. Nordlinger B, Guiget M, Vaillant J-C, Balladur P, Boudjema K, Bachellier P, Jaeck D: Surgical resection of colorectal carcinoma metastases to the liver: a prognostic scoring system to improve case selection, based on 1568 patients. Cancer 1996, 77(7):1254-1262 Key retrospective review of 1,568 patients, with estimation of independent variables influencing outcome and suggesting a scoring system for selection of patients suitable for hepatic resection.
23. Taylor I: Liver metastases from colorectal cancer: lessons from past and present clinical studies. Br J Surg 1996, 83:456-460.
24. Adam R, Bismuth H, Castaing D, Waechter F, Navarro F, Abascal A, • Majno P, Engerran L: Repeat hepatectomy for colorectal liver metastases. Ann Surg 1997, 225(1):51-62. Important review of 83 repeat hepatic resections for metastatic colorectal cancer demonstrating morbidity and survival levels approximately equivalent to those for first-time resection.
25. Pinson C, Wright J, Chapman W, Garrard C, Blair T, Sawyers J: Repeat hepatic surgery for colorectal cancer metastases to the liver. Ann Surg 1996, 223(6):765-773.
26. Isenberg J, Fischbach R, Kruger I, Keller H: Treatment of liver metastases from colorectal cancer. Anticancer Res 1996, 16:1291-1296.
27. Benhattar J, Cerottini J, Saraga E, Metthez G, Givel J: p53 Mutations as a possible predictor of response to chemotherapy in metastatic colorectal carcinomas. Int J Cancer 1996, 69(3):190-192.
28. Preketes A, Caplehorn J, King J, Clingan P, Ross W, Morris D: Effect of hepatic artery chemotherapy on survival of patients with hepatic metastases from colorectal carcinoma treated with cryotherapy. World J Surg 1995, 19:768-771.
29. Meta-analysis Group in Cancer: Reappraisal of hepatic arterial infusion •• in the treatment of nonresectable liver metastases from colorectal cancer. J Natl Cancer Inst 1996, 88:252-258. Major meta-analysis of all trials of HAI for a 5-year period demonstrating improved survival over no treatment control groups, but not over systemic chemotherapy control subjects.
30. Adam R, Akpinar E, Johann M, Kunstlinger F, Majno P, Bismuth H: Place of cryosurgery in the treatment of malignant liver tumors. Ann Surg 1997, 225(1):39-50.
31. Wade T, Virgo K, Li M, Callander P, Longo W, Johnson F: Outcomes •• after detection of metastatic carcinoma of the colon and rectum in a national hospital system. J Am Coll Surg 1996, 182(4):353-361. This article reviews outcome of more than 22,000 patients treated for colorectal cancer in the United States Veterans system and estimates projected costs of a screening program for liver metastases.
32. Hoshino K, Kawaguchi H, Unate H, Nitta K, Fukui H, Ikeda M, Tsujitani S: A case of AFP producing gastric cancer successfully treated with FEP (5-FU, Epirubicin, cisplatin) therapy by continuous venous daily infusion of 5-FU and low dose CDDP. Japn J Cancer Chemother 1996, 23(9):1197-1200.
33. Sakata Y, Okamura T, Kurimoto H, Ono K, Fuku A: A case of advanced gastric cancer with lung and liver metastasis treated by CDDP and 5-FU. Japn J Cancer Chemother 1996, 23(5):627-630.
34. Nakagawa H, Kobayashi K, Tono T, Fukuda K, Shinn E, Mishima H, Yagyu T, Kobayashi T, Kikkawa N: Combination of intra-hepatic arterial infusion of low dose cisplatin and oral administration of high dose doxyfluridine for patients with liver metastases of gastric cancer. Japn J Cancer Chemother 1996, 23(6):783-785.